Across 28 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by 이혁재, Vice-Président. Officer active across 2 companies, notably 인바이오. Aggregated, 45 filings have been published. History available since 12 January 2026. The latest transaction was filed on 27 March 2026 (Purchase). Regulator: DART (FSS). The full history is free.
Lee Hyuk-jae is the vice president at Inbio, a company specializing in biotechnology. He plays a key role in the company's leadership, overseeing operations and contributing to the development of strategies aimed at strengthening its market position. His leadership is essential for achieving the company's goals.